Quest Diagnostics Inc (DGX.N)
|Market Cap (Mil.):||$9,031.69|
|Shares Outstanding (Mil.):||144.41|
PARIS - Eighteen French biotech firms, several newly listed on the Paris stock market, head to New York on Wednesday and Thursday to convince U.S. investors to help fund the next stages of their research and development.
- Laboratory tests provider Quest Diagnostics Inc's first-quarter adjusted profit fell short of analysts' expectations, as an unusually harsh U.S. winter deterred people from going to its centers for tests.
April 24 - Laboratory tests provider Quest Diagnostics Inc's first-quarter adjusted profit fell short of analysts' expectations, as an unusually harsh U.S. winter deterred people from going to its centers for tests.
|Laboratory Corp. of America Holdings (LH.N)||$106.72||+0.57|
|Bio-Reference Laboratories Inc (BRLI.OQ)||$31.56||-0.14|
|Sonic Healthcare Limited (SHL.AX)||$17.54||-0.21|
|Ventas, Inc. (VTR.N)||$65.94||+0.04|
|Johnson & Johnson (JNJ.N)||$104.18||+0.97|
|GlaxoSmithKline plc (GSK.L)||1,434.50p||+17.00|
|Pfizer Inc. (PFE.N)||$28.87||-0.02|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Trading Report for (DGX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: MarketLine (a Datamonitor Company)
"The Economy Matters" Report for DGX: the economy's impact on DGX's price and risk, featuring the powerful Economic Climate Rating
Provider: MacroRisk Analytics/EconomicInvestor
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.